HSPB8 and breast cancer: Since HSPB8 has been shown to induce MCF-7 cell proliferation (21), we postulated that the well-known antiproliferative action exerted by RA on BC cells may also take place through the downregulation of HSPB8 and its co-chaperone BAG3.